Breaking News
December 10, 2018 - Scientists find answers to how cancer spreads
December 10, 2018 - Study explores why older people read more slowly
December 10, 2018 - Asbestos found in most NHS hospitals finds BBC inquiry
December 10, 2018 - Researchers use new technique to probe hydrogen bonds
December 10, 2018 - Music improves social communication in autistic children
December 10, 2018 - Some Brain Tumors May Respond to Immunotherapy, New Study Suggests
December 10, 2018 - Banning junk food ads to combat childhood obesity
December 10, 2018 - Skin Autofluorescence Predicts T2DM, Heart Disease, Mortality
December 10, 2018 - Largest autism sequencing study to date yields 102 genes associated with ASD
December 10, 2018 - Statins associated with low risk of side effects
December 10, 2018 - Study explores how schools address adolescent self-harming practices
December 10, 2018 - Pregnancy in adolescence linked to increased risks of complications in young mothers
December 10, 2018 - Risk Analysis publishes special issue on communicating about Zika virus
December 10, 2018 - Botox May Help Prevent Post-Op A-Fib
December 10, 2018 - African-American mothers rate boys higher for ADHD
December 10, 2018 - Graphic warning labels cancel out cigarettes’ appeal to young people
December 10, 2018 - Australian researchers to study gas inhalational anaesthetic and likelihood of cancer return
December 10, 2018 - Individual neurons located within the brain have implications for psychiatric diseases
December 10, 2018 - Researchers improve bariatric surgery scoring system to extend prediction time for diabetic remission
December 10, 2018 - HPV type 16 or 18 associated with cervical cancer risk in young women
December 10, 2018 - Cervical cancer risk is higher in women with positive HPV, but no cellular abnormalities
December 10, 2018 - Combo therapy not needed if low RA disease activity achieved
December 10, 2018 - Novel therapeutic targets based on biology of aging show promise for Alzheimer’s disease
December 10, 2018 - UC San Diego professor receives NCI Outstanding Investigator Award for cancer research
December 10, 2018 - Study evaluates placental mesenchymal stem cell sheets for myocardial repair and regeneration
December 10, 2018 - Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis
December 10, 2018 - Study clarifies ApoE4’s role in dementia
December 10, 2018 - Eating disorders now a top priority with Australian Government
December 10, 2018 - Neuronal activity in the brain allows prediction of risky or safe decisions
December 10, 2018 - FDA Alerts Health Care Professionals and Patients Not to Use Drug Products Intended to be Sterile from Promise Pharmacy
December 10, 2018 - Improving dementia care and treatment saves thousands of pounds in care homes
December 10, 2018 - Heroin-assisted treatment can offer benefits, reduce harms
December 10, 2018 - People covered by Michigan’s expanded Medicaid program report improvements in health, finds study
December 10, 2018 - Hazelnuts improve micronutrient levels in older adults
December 9, 2018 - History of Partner Violence Tied to Menopause Symptoms
December 9, 2018 - Clean Up Safely After a Disaster|Natural Disasters and Severe Weather
December 9, 2018 - Drug wholesalers drove fentanyl’s deadly rise, report concludes
December 9, 2018 - Deprescribing could help manage polypharmacy in older adults
December 9, 2018 - Retraction of article “Joy of cooking too much” from journal
December 9, 2018 - FDA Warns of Rare Stroke Risk With MS Drug Lemtrada (Alemtuzumab)
December 9, 2018 - Feds say heroin, fentanyl remain biggest drug threat to US
December 9, 2018 - Eliminating microglia can reverse some aspects of stress sensitization, study shows
December 9, 2018 - New genetic insight could help treat rare debilitating heart and lung condition
December 9, 2018 - MiRagen Therapeutics Announces Final Safety, Biodistribution and Clinical Efficacy Data From Phase 1 Cobomarsen Clinical Trial in Patients With Mycosis Fungoides
December 9, 2018 - Work with your doctor to weigh pros, cons of treatment options for hyperthyroidism
December 9, 2018 - CWRU researcher secures $14.6 million funding for genetic study into Alzheimer’s disease
December 9, 2018 - High intensity statin treatment and adherence could save more lives
December 9, 2018 - Surgery patients use only 1/4 of prescribed opioids, and prescription size matters
December 9, 2018 - AXT offers Phi Optics upgrade to QPI systems for inverted light microscopes
December 9, 2018 - New booklet could help improve conditions of young pupils with albinism
December 9, 2018 - Few Physicians Work in Practices That Use Telemedicine
December 9, 2018 - Older Adults and Oral Health
December 9, 2018 - Health utility values improve after septorhinoplasty
December 9, 2018 - New EU-funded project provides insight into how the brain develops
December 9, 2018 - Expanded use of tele-emergency services can help strengthen rural hospitals
December 9, 2018 - Infections in the Young May Be Tied to Risk for Mental Illness: Study
December 9, 2018 - Profile: Native Hawaiians and Pacific Islanders
December 9, 2018 - Snoring poses greater cardiac risk to women
December 9, 2018 - Researcher takes further steps in understanding how and why cute aggression occurs
December 9, 2018 - Researchers create new light-activated tools for controlling neurons
December 9, 2018 - Spinal cord injury disrupts the body’s internal clock, study shows
December 9, 2018 - Babies recognize nested structures similar to our grammar
December 9, 2018 - UT Austin researcher receives $2.5 million CZI grant for neurodegenerative disease research
December 9, 2018 - Sleep problems found to be prevalent and increasing among college students
December 9, 2018 - Study reveals why some children are susceptible to the effects of maltreatment
December 9, 2018 - Study investigates influence of different opioids on driving performance
December 9, 2018 - Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia
December 9, 2018 - Eliminating microglia prevents heightened immune sensitivity after stress
December 9, 2018 - Boys with social difficulties are at greatest risk of early substance use
December 9, 2018 - ‘Wrong’ connective tissue cells linked to worse prognosis in breast cancer patients
December 8, 2018 - Chronic, refractory schizophrenia patients benefit from targeted cognitive training
December 8, 2018 - Advertising in kids’ apps more prevalent than parents may realize
December 8, 2018 - New way to trace the transmission histories of rare genetic diseases
December 8, 2018 - ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma
December 8, 2018 - Results of pediatric genomic epilepsy tests often reclassified
December 8, 2018 - New way of controlling HIV latency to completely eradicate the virus
December 8, 2018 - Phasefocus to showcase the Livecyte 2 at ASCB
December 8, 2018 - KHN’s ‘What the Health?’ Is health spending the next big political issue?
December 8, 2018 - Mussels take in microplastic pollution fibers and flush most of them out again
December 8, 2018 - AHA: How to Stop Smoking … for Good
Fine particle air pollution is a public health emergency hiding in plain sight

Fine particle air pollution is a public health emergency hiding in plain sight

image_pdfDownload PDFimage_print

Current evidence suggests that PM2.5 alone causes more deaths and illnesses than all other environmental exposures combined. For that reason, one of us (Douglas Brugge) recently wrote a book to try to spread the word to the broader public.

Developed countries have made progress in reducing particulate air pollution in recent decades, but much remains to be done to further reduce this hazard. And the situation has gotten dramatically worse in many developing countries – most notably, China and India, which have industrialized faster and on vaster scales than ever seen before. According to the World Health Organization, more than 90 percent of the world’s children breathe air so polluted it threatens their health and development.

As environmental health specialists, we believe the problem of fine particulate air pollution deserves much more attention, including in the United States. New research is connecting PM2.5 exposure to an alarming array of health effects. At the same time, the Trump administration’s efforts to support the fossil fuel industry could increase these emissions when the goal should be further reducing them.

Where there’s smoke …

Particulate matter is produced mainly by burning things. In the United States, the majority of PM2.5 emissions come from industrial activities, motor vehicles, cooking and fuel combustion, often including wood. There is a similar suite of sources in developing countries, but often with more industrial production and more burning of solid fuels in homes.

Wildfires are also an important and growing source, and winds can transport wildfire emissions hundreds of miles from fire regions. In August 2018, environmental regulators in Michigan reported that fine particles from wildfires burning in California were impacting their state’s air quality.

Coverage of an air quality alert in Delhi and neighboring cities, Nov. 5, 2018.

Most deaths and many illnesses caused by particulate air pollution are cardiovascular – mainly heart attacks and strokes. Obviously, air pollution affects the lungs because it enters them as we breathe. But once PM enters the lungs, it causes an inflammatory response that sends signals throughout the body, much as a bacterial infection would. Additionally, the smallest particles and fragments of larger particles can leave the lungs and travel through the blood.

Emerging research continues to expand the boundaries of health impacts from PM2.5 exposure. To us, the most notable new concern is that it appears to affect brain development and has adverse cognitive impacts. The smallest particles can even travel directly from the nose into the brain via the olfactory nerve.

There is growing evidence that PM2.5, as well as even smaller particles called ultrafine particles, affect children’s central nervous systems. They also can accelerate the pace of cognitive decline in adults and increase the risk in susceptible adults of developing Alzheimer’s disease.

PM2.5 has received much of the research and policy attention in recent years, but other types of particles also raise concerns. Ultrafines are less studied than PM2.5 and are not yet considered in risk estimates or air pollution regulations. Coarse PM, which is larger and typically comes from physical processes like tire and brake wear, may also pose health risks.

Regulatory push and pull

The progress that developed countries have made in addressing air pollution, especially PM, demonstrates that regulation works. Before the U.S. Environmental Protection Agency was established in 1970, air quality in Los Angeles, New York and other major U.S. cities bore a striking resemblance to Beijing and Delhi today. Increasingly stringent air pollution regulations enacted since then have protected public health and undoubtedly saved millions of lives.

But it wasn’t easy. The first regulatory limits on PM2.5 were proposed in the 1990s, after two important studies showed that it had major health impacts. But industry pushback was fierce, and included accusations that the science behind the studies was flawed or even fraudulent. Ultimately federal regulations were enacted, and follow-up studies and reanalysis confirmed the original findings.

EPA”>
Fine particle air pollution is a public health emergency hiding in plain sight
U.S. counties failing to meet national standards for at least one of six major air pollutants regulated under the Clean Air Act: PM2.5, PM10, sulfur dioxide, carbon monoxide, nitrogen dioxide and eight-hour ozone. Credit: EPA

Now the Trump administration is working to reduce the role of science in shaping air pollution policy and reverse regulatory decisions by the Obama administration. One new appointee to the EPA’s Science Advisory Board, Robert Phalen, a professor of medicine at the University of California, Irvine, is known for asserting that modern air is actually too clean for optimal health, even though the empirical evidence does not support this argument.

On Oct. 11, 2018, EPA Administrator Andrew Wheeler disbanded a critical air pollution science advisory group that dealt specifically with PM regulation. Critics called this an effort to limit the role that current scientific evidence plays in establishing national air quality standards that will protect public health with an adequate margin of safety, as required under the Clean Air Act.

Opponents of regulating PM2.5 in the 1990s at least acknowledged that science had a role to play, although they tried to discredit studies that supported the case for regulation. The new approach seems to be to try to cut scientific evidence out of the process entirely.

No time for complacency

In late October 2018, the World Health Organization convened a special conference on global air pollution and health. The agency’s heightened interest appears to be motivated by risk estimates that show air pollution to be a concern of similar magnitude to more traditional public health targets, such as diet and physical activity.

Conferees endorsed a goal of reducing global deaths from air pollution by two-thirds by 2030. This is a highly aspirational target, but it may focus renewed attention on strategies such as reducing economic barriers that make it hard to deploy pollution control technologies in developing countries.

In any case, past and current research clearly show that now is not the time to move away from regulating air pollution that arises largely from burning fossil fuels, in the United States or abroad.


Explore further:
Air pollution linked to autism: study

Provided by:
The Conversation

Tagged with:

About author

Related Articles